deferiprone has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intramyocardial hemorrhage is an independent predictor of adverse outcomes in ST-segment elevation myocardial infarction (STEMI)." | 1.56 | Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction. ( Barry, J; Behrouzi, B; Connelly, J; Ghugre, NR; Manca, D; Qi, X; Rabadia, V; Spino, M; Strauss, BH; Weyers, JJ; Wood, JC; Wright, GA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pepe, A | 1 |
| Meloni, A | 1 |
| Filosa, A | 1 |
| Pistoia, L | 1 |
| Borsellino, Z | 1 |
| D'Ascola, DG | 1 |
| Lisi, R | 1 |
| Putti, MC | 1 |
| Allò, M | 1 |
| Gamberini, MR | 1 |
| Quarta, A | 1 |
| Fidone, C | 1 |
| Casini, T | 1 |
| Restaino, G | 1 |
| Midiri, M | 1 |
| Mangione, M | 1 |
| Positano, V | 1 |
| Casale, M | 1 |
| Behrouzi, B | 1 |
| Weyers, JJ | 1 |
| Qi, X | 1 |
| Barry, J | 1 |
| Rabadia, V | 1 |
| Manca, D | 1 |
| Connelly, J | 1 |
| Spino, M | 1 |
| Wood, JC | 1 |
| Strauss, BH | 1 |
| Wright, GA | 1 |
| Ghugre, NR | 1 |
2 other studies available for deferiprone and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network.
Topics: Adolescent; Age Factors; beta-Thalassemia; Cardiomyopathies; Child; Deferiprone; Deferoxamine; Femal | 2020 |
Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction.
Topics: Animals; Cardiotonic Agents; Deferiprone; Disease Models, Animal; Female; Hemorrhage; Iron Chelating | 2020 |